Abstract:Following the publication of the above article, the authors contacted the Editorial Office to explain that they had identified a pair of duplicate images in the control (Vehicle) group of mouse images in Fig. 1A on p. 1792. Specifically, the same image (corresponding correctly to the 'Day 5' experiment) was inadvertently chosen to represent the cutaneous manifestations of mice in the Vehicle group on 'Day 3' and 'Day 5' in Fig. 1A. This error arose as a consequence of repetitive application and duplication procedures within the image set, resulting in the inadvertent reuse of the same photo. Additionally, due to minimal alterations observed in the skin condition of mice from the control group following treatment, each mouse exhibited a similar appearance; this similarity further contributed to the delayed identification of this error during the paper revision stage. Consequently, this duplication of the same image was made as a result of insufficient scrutiny. The revised version of Fig. 1, showing the correct image for the 'Day 3' experiment in Fig. 1A, is shown on the next page. The authors can confirm that the error associated with the assembly of this figure did not have any significant impact on either the results or the conclusions reported in this study, and all the authors agree with the publication of this Corrigendum. The authors are grateful to the Editor of International Journal of Molecular Medicine for allowing them the opportunity to publish this; furthermore, they apologize to the readership of the Journal for any inconvenience caused. [International Journal of Molecular Medicine 43: 1789‑1805, 2019; DOI: 10.3892/ijmm.2019.4098].

Correction: Corrigendum: CD95 promotes tumour growth

Erratum: CD95 promotes tumour growth

Erratum: CD95 promotes tumour growth (Nature (2010) 465 (492-496))

[Corrigendum] Upregulation of centromere protein M promotes tumorigenesis: A potential predictive target for cancer in humans

Erratum: Artemin is estrogen regulated and mediates antiestrogen resistance in mammary carcinoma

Corrigendum: Tumor-Associated Macrophages in Tumor Immunity

Correction To: TAOK1 Negatively Regulates IL-17-mediated Signaling and Inflammation

Correction: Corrigendum: Autophagy-associated alpha-arrestin signaling is required for conidiogenous cell development in Magnaporthe oryzae

[Corrigendum] Azurocidin 1 inhibits the aberrant proliferation of triple‐negative breast cancer through the regulation of pyroptosis

Correction: Corrigendum: Selective Killing of Cancer Cells by a Small Molecule Targeting the Stress Response to ROS

Author Correction: Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours

[Corrigendum] Antiproliferative effect of alpinetin in BxPC-3 pancreatic cancer cells

Correction: Corrigendum: Reduced cell proliferation by IKK2 depletion in a mouse lung-cancer model

Erratum: CD151 promotes Colorectal Cancer progression by a crosstalk involving CEACAM6, LGR5 and Wnt signaling via TGFβ1: Erratum.

[Corrigendum] All‑ trans retinoic acid alters the expression of the tight junction proteins Claudin‑1 and ‑4 and epidermal barrier function‑associated genes in the epidermis

[Corrigendum] Omi/HtrA2 pro-apoptotic marker differs in various hepatocellular carcinoma cell lines owing to ped/pea-15 expression level

Corrigendum: T lymphocyte cell: A pivotal player in lung cancer

Correction: Wang et al. TERT Promoter Revertant Mutation Inhibits Melanoma Growth through Intrinsic Apoptosis. Biology 2022, 11, 141

[Corrigendum] Jak3 is involved in CCR7‐dependent migration and invasion in metastatic squamous cell carcinoma of the head and neck

[Corrigendum] Effects of miR‑340 overexpression and knockdown on the proliferation and metastasis of NSCLC cell lines

Correction to: The phosphorylation of CD147 by Fyn plays a critical role for melanoma cells growth and metastasis